Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine
Deshmukh, Atul S, Peijs, Lone, Beaudry, Jacqueline L, Jespersen, Naja Z, Nielsen, Carsten H, Ma, Tao, Brunner, Andreas D, Larsen, Therese J, Bayarri-Olmos, Rafael, Prabhakar, Bhargav S, Helgstrand, Charlotte, Severinsen, Mai C K, Holst, Birgitte, Kjaer, Andreas, Tang-Christensen, Mads, Sanfridson, Annika, Garred, Peter, Privé, Gilbert G, Pedersen, Bente K, Gerhart-Hines, Zachary, Nielsen, Søren, Drucker, Daniel J, Mann, Matthias, Scheele, Camilla
Published in Cell metabolism (05.11.2019)
Published in Cell metabolism (05.11.2019)
Get full text
Journal Article
Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
Christoffersen, Berit Ø., Skyggebjerg, Rikke Bjerring, Bugge, Anne, Kirk, Rikke Kaae, Vestergaard, Bill, Uldam, Henriette Kold, Fels, Johannes Josef, Pyke, Charles, Sensfuss, Ulrich, Sanfridson, Annika, Clausen, Trine Ryberg
Published in International Journal of Obesity (01.02.2020)
Published in International Journal of Obesity (01.02.2020)
Get full text
Journal Article
Safety, efficacy and biomarker data in patients with non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab in combination with platinum doublet
Paz-Ares, Luis G., Paulus, Astrid, Zemaitis, Marius, Cicenas, Saulius, Zvirbule, Zanete, Felip, Enriqueta, Sanfridson, Annika, Rydberg-Millrud, Camilla, Magnusson, Susanne, Losic, Nedjad, Garcia-Ribas, Ignacio
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Efficacy and safety of the anti-IL1RAP antibody nadunolimab (CAN04) in combination with gemcitabine and nab-paclitaxel in patients with advanced/metastatic pancreatic cancer
Van Cutsem, Eric, Collignon, Joelle, Eefsen, Rikke L, Ochsenreither, Sebastian, Zvirbule, Zanete, Ivanauskas, Audrius, Arnold, Dirk, Baltruskeviciene, Edita, Pfeiffer, Per, Yachnin, Jeffrey, Magnusson, Susanne, Rydberg Millrud, Camilla, Sanfridson, Annika, Losic, Nedjad, Garcia-Ribas, Ignacio, Tersago, Dominique, Awada, Ahmad
Published in Clinical cancer research (10.10.2024)
Published in Clinical cancer research (10.10.2024)
Get full text
Journal Article
145 Nadunolimab inhibits IL-1α/β-induced CXCR1/2 ligand expression and reduces serum levels of CXCL1 and CXCL5 in NSCLC and PDAC patients
Millrud, Camilla, Gyllenbäck, Elin, Skoog, Petter, Sanfridson, Annika, Liberg, David
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article
Abstract C002: Interleukin-1 receptor accessory protein (IL1RAP) overexpression is associated with worse prognosis in PDAC and is targetable by nadunolimab
Van Cutsem, Eric, Abdilleh, Kawther, Datta, Jashodeep, Hidalgo, Manuel, Millrud, Camilla Rydberg, Skoog, Petter, Sanfridson, Annika, Tersago, Dominique, Liberg, David
Published in Cancer research (Chicago, Ill.) (16.01.2024)
Published in Cancer research (Chicago, Ill.) (16.01.2024)
Get full text
Journal Article
Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets
Enoksson, Mari, Martin, Erika J., Holmberg, Heidi, Jensen, Mette S., Kjelgaard‐Hansen, Mads, Egebjerg, Thomas, Buchardt, Jens, Krogh, Thomas N., Demuth, Helle, Sanfridson, Annika, Hilden, Ida, Kjalke, Marianne, Brophy, Donald F.
Published in Journal of thrombosis and haemostasis (01.01.2020)
Published in Journal of thrombosis and haemostasis (01.01.2020)
Get full text
Journal Article
Abstract 2172: Tumor IL1RAP levels and reduction in serum biomarkers correlate with response in PDAC patients treated with nadunolimab, an anti-IL1RAP monoclonal antibody, in combination with gemcitabine and nab-paclitaxel
Van Cutsem, Eric, Collignon, Joelle, Eefsen, Rikke, Ochsenreither, Sebastian, Zvirbule, Zanete, Ivanauskas, Audrius, Millrud, Camilla Rydberg, Skoog, Petter, Losic, Nedjad, Magnusson, Susanne, Sanfridson, Annika, Liberg, David
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
선택적인 PYY 화합물 및 그것의 사용
WULFF BIRIGTTE SCHJELLERUP, SANFRIDSON ANNIKA, OSTERGAARD SOREN, JESSEN CARSTEN
Year of Publication 26.02.2018
Get full text
Year of Publication 26.02.2018
Patent
Inflammatory pathway analysis using a high content screening platform
Bertelsen, Malene, Sanfridson, Annika
Published in Assay and drug development technologies (01.06.2005)
Published in Assay and drug development technologies (01.06.2005)
Get more information
Journal Article
SELECTIVE PYY COMPOUNDS AND USES THEREOF
STERGAARD, S?ren, JESSEN, Carsten, WULFF, Birigtte Schjellerup, SANFRIDSON, Annika
Year of Publication 27.08.2021
Get full text
Year of Publication 27.08.2021
Patent
Selective PYY compounds and uses thereof
Østergaard, Soren, Sanfridson, Annika, Jessen, Carsten, Wulff, Birigtte Schjellerup
Year of Publication 06.02.2020
Get full text
Year of Publication 06.02.2020
Patent
SELECTIVE PYY COMPOUNDS AND USES THEREOF
JESSEN, Carsten, WULFF, Birigtte Schjellerup, ØSTERGAARD, Søren, SANFRIDSON, Annika
Year of Publication 28.08.2019
Get full text
Year of Publication 28.08.2019
Patent
COMPOSÉS PYY SÉLECTIFS ET LEURS UTILISATIONS
JESSEN, Carsten, WULFF, Birigtte Schjellerup, ØSTERGAARD, Søren, SANFRIDSON, Annika
Year of Publication 19.09.2018
Get full text
Year of Publication 19.09.2018
Patent